Huvitz Co., Ltd. (KOSDAQ:065510)
7,720.00
0.00 (0.00%)
At close: May 4, 2026
Huvitz Revenue
In the year 2025, Huvitz had annual revenue of 118.04B KRW with 0.14% growth. Huvitz had revenue of 27.53B in the quarter ending December 31, 2025, a decrease of -8.38%.
Revenue
118.04B
Revenue Growth
+0.14%
P/S Ratio
0.69
Revenue / Employee
452.27M
Employees
261
Market Cap
80.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 118.04B | 168.17M | 0.14% |
| Dec 31, 2024 | 117.88B | 138.16M | 0.12% |
| Dec 31, 2023 | 117.74B | 8.96B | 8.23% |
| Dec 31, 2022 | 108.78B | 13.76B | 14.48% |
| Dec 31, 2021 | 95.02B | 24.93B | 35.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UBIVELOX | 667.89B |
| SEKONIX | 434.87B |
| Shin Steel | 352.17B |
| TEMC CNS | 168.04B |
| Jeil M&S | 151.27B |
| Icure Pharmaceutical Incorporation | 83.38B |
| Mr. Blue | 67.46B |
| Incross | 50.49B |